Delivered-To: tjphuhs@gmail.com Received: by 2002:adf:e988:0:b0:435:ab39:4520 with SMTP id h8csp153019wrm; Wed, 11 Feb 2026 07:30:21 -0800 (PST) X-Received: by 2002:a05:622a:134a:b0:4ec:f6d5:ee46 with SMTP id d75a77b69052e-50639a1cf8fmr272974201cf.78.1770823820855; Wed, 11 Feb 2026 07:30:20 -0800 (PST) ARC-Seal: i=1; a=rsa-sha256; t=1770823820; cv=none; d=google.com; s=arc-20240605; b=Z6enfGKT0Sqa6GRhnS1l2d5WIcUlmhZoPr3Poys48CxGCj7+b/oQkit0vvLf99VhBz Kn3rlT1NdnLoBMP8VPCGXUn/W5ayZjkyR2BVjS2v5R9wZgaQy1q11kUZtQjgmGgaMXw3 DoOl2idSnAE3r6zadKrzKZBVkwjTdLk2MYn4MVfXXmT2PuwIY0yEBqQ3fccxYFlFEJ9z Lf8gVgVjBpGw16vbbHo1YRaCOtcCu+F9u3sXjPyMJp6i0Doz3NAxPbm3Q+zymks/eyPp JH7vW/SaDkdWd9afVL5OD1UynBeM2x7eHEdJ9xwuhtN0ask+9ovDlOcox5ts8AqyokOh g+Yg== ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20240605; h=message-id:feedback-id:list-unsubscribe:list-unsubscribe-post:to :from:subject:mime-version:date:sender:dkim-signature:dkim-signature; bh=+VPBqTbpg9a9YatNqiMkjo6M6aSAhtJYB1NCDb5sW98=; fh=9zP21OW67FFZD2VV42mGudo540Qp4aalMWxJB5kMYug=; b=QeSpiHFC+rzseiZe+vh0DjEMiaSR6zLbN0kwotRJpoHHAZGBooAcTyQ37x2CAVi61B SDn6KoJZLb33tY1U+oBPPTe+XrtUMnt6rZX02BPWwUSqfgpyMukfnrWzhUcdozCLqmq4 sF+i0nt5eMh+Bh20OZGyMq5C5GycSbL6JAK2vftaPBS2BjK5WtQCtiUHJl60TxXpsjDo 6Yf0eDfuOgptmROcV815XhCsfHdf6t67EYAJpYAf+xpahZ7u+sHV99dzr4Nmyuhpxjbs uKiDQ400DryzQgCmPcAYm1v7B1gTg5W7Elzj5r61779UH2mBWi8+yLZXD0G1c2pKYeCQ dh8A==; dara=google.com ARC-Authentication-Results: i=1; mx.google.com; dkim=pass header.i=@somachems.com header.s=smtp header.b=hMf+iLB3; dkim=pass header.i=@mailgun.org header.s=mg header.b=e7cadNFk; spf=pass (google.com: domain of bounce+adcffc.796d49-tjphuhs=gmail.com@somachems.com designates 204.220.169.128 as permitted sender) smtp.mailfrom="bounce+adcffc.796d49-tjphuhs=gmail.com@somachems.com"; dmarc=pass (p=QUARANTINE sp=QUARANTINE dis=NONE) header.from=somachems.com Return-Path: Received: from g128.gb126d70.use4.send.mailgun.net (g128.gb126d70.use4.send.mailgun.net. [204.220.169.128]) by mx.google.com with UTF8SMTPS id af79cd13be357-8cb2b1e8d96si172663285a.291.2026.02.11.07.30.20 for (version=TLS1_2 cipher=ECDHE-ECDSA-AES128-GCM-SHA256 bits=128/128); Wed, 11 Feb 2026 07:30:20 -0800 (PST) Received-SPF: pass (google.com: domain of bounce+adcffc.796d49-tjphuhs=gmail.com@somachems.com designates 204.220.169.128 as permitted sender) client-ip=204.220.169.128; Authentication-Results: mx.google.com; dkim=pass header.i=@somachems.com header.s=smtp header.b=hMf+iLB3; dkim=pass header.i=@mailgun.org header.s=mg header.b=e7cadNFk; spf=pass (google.com: domain of bounce+adcffc.796d49-tjphuhs=gmail.com@somachems.com designates 204.220.169.128 as permitted sender) smtp.mailfrom="bounce+adcffc.796d49-tjphuhs=gmail.com@somachems.com"; dmarc=pass (p=QUARANTINE sp=QUARANTINE dis=NONE) header.from=somachems.com DKIM-Signature: a=rsa-sha256; v=1; c=relaxed/relaxed; d=somachems.com; q=dns/txt; s=smtp; t=1770823820; x=1770831020; h=Message-Id: List-Unsubscribe: List-Unsubscribe-Post: To: To: From: From: Subject: Subject: Content-Type: Mime-Version: Date: Sender: Sender: X-Feedback-Id; bh=+VPBqTbpg9a9YatNqiMkjo6M6aSAhtJYB1NCDb5sW98=; b=hMf+iLB3OsWAzqTMHjT5p/8eDxG0nExfakQ/GL2AAtPm4V1V8X/Hz9M1dHfCz28n5hKOLAogYf7CYvv/MXT+dh7HHw+eVG80wpQAJVOS5zGOnZOOLDimDe4V/vRNFqJcz+fOc1u0JTPibeNC5Ob7GXcc38w/w0KisVnp7UH+FUs= DKIM-Signature: a=rsa-sha256; v=1; c=relaxed/relaxed; d=mailgun.org; q=dns/txt; s=mg; t=1770823820; x=1770831020; h=Message-Id: List-Unsubscribe: List-Unsubscribe-Post: To: To: From: From: Subject: Subject: Content-Type: Mime-Version: Date: Sender: Sender: X-Feedback-Id; bh=+VPBqTbpg9a9YatNqiMkjo6M6aSAhtJYB1NCDb5sW98=; b=e7cadNFk57/mMmI0bE5EgKviuyzkvn22IpLPXD1LnZPMHqU0onRvS/yfiQN49qiDuGL6HsKrEVVgyXa/5Q6QiTSGyJ0cmpvwpjImyUlZyAZSzcQ4Cs/Pf1hhKibgsfdlsGcSEJ78lolsMQSR1R+9CrLfkDq8nYwdX5sxYKuvr4I= X-Mailgun-Sid: WyJkMGJjMCIsInRqcGh1aHNAZ21haWwuY29tIiwiNzk2ZDQ5Il0= X-Feedback-Id: info@somachems.com::686788436b43ce5dfdf26b4b:mailgun Received: by bd680643cdf6bcadc6000befdabc8eb4f090ccce763be320a19ba1c54637adba with HTTP id 698ca08bf590eca322f1f552; Wed, 11 Feb 2026 15:30:15 GMT X-Mailgun-Sending-Ip-Pool-Name: BstS X-Mailgun-Sending-Ip-Pool: 665596289f43bfa346f3584f X-Mailgun-Sending-Ip: 204.220.169.128 X-Mailgun-Batch-Id: 698ca087d9cada3596b97b56 Sender: info@somachems.com Date: Wed, 11 Feb 2026 15:30:15 +0000 Mime-Version: 1.0 Content-Type: multipart/alternative; boundary="2cb382b13505d730ef48f2b7df7c7fe2a45023ff3991e04700510bcddd3d" Subject: =?UTF-8?b?8J+YsSBHTFAtMyAoUkVUQSkgdnMgTU9UUy1DIPCfmLE=?= From: SOMA CHEMS To: tjphuhs@gmail.com X-Mailgun-Track: false List-Unsubscribe-Post: List-Unsubscribe=One-Click List-Unsubscribe: Feedback-Id: 698b472a80aeb744222d4371:686794eb7d5d9b4678a0be3a:campaign:omnisend X-Mailgun-Variables: {"brandID": "686794eb7d5d9b4678a0be3a", "contactID": "68a3ebb905e51bffe64c8eaf", "progressID": "698c2a47dd9732c63e198315"} Message-Id: <20260211153015.dfbf10efa2f6f846@somachems.com> --2cb382b13505d730ef48f2b7df7c7fe2a45023ff3991e04700510bcddd3d Content-Type: text/plain; charset="utf-8" Content-Transfer-Encoding: quoted-printable Take your metabolic research to the next level This email was sent to you as HTML-only. To view it, please visit:=20 https://qfq.soundestlink.com/ce/v/68a3ebb905e51bffe64c8eaf/698c2a47dd9732c6= 3e198315 ************************** Make sure you keep getting our latest offers and add info@somachems.com to = your address book. Unsubscribe=20 https://qfq.soundestlink.com/contactsPreferences/v2/unsubscribe/?b=3D686794= eb7d5d9b4678a0be3a&c=3D68a3ebb905e51bffe64c8eaf&payload=3D9jvPk7ft5w7phOtam= 7uB0xVvTcA5OZdje2w5yeYGfqyiHSARbs65vY9Hkce8YJ2gN4naeTF2MJUK_dTt1dzN-oY2uqn1= fndnLY65XkW-uTmhteJBSXtOqXzoi0XzO43H8aZi Visit site https://somachems.com =C2=96 --2cb382b13505d730ef48f2b7df7c7fe2a45023ff3991e04700510bcddd3d Content-Type: text/html; charset="utf-8" Content-Transfer-Encoding: quoted-printable =F0=9F=98=B1 GLP-3 (RETA) vs MOTS-C =F0=9F=98=B1

= Take your metabolic research to the next level

͏ ͏ ͏ ͏ ͏ ͏ &= #847; ͏ ͏ ͏ ͏ ͏ T= 7; ͏ ͏ ͏ ͏ ͏ ͏&= nbsp;͏ ͏ ͏ ͏ ͏ ͏&nbs= p;͏ ͏ ͏ ͏ ͏ ͏ &= #847; ͏ ͏ ͏ ͏ ͏ T= 7; ͏ ͏ ͏ ͏ ͏ ͏&= nbsp;͏ ͏ ͏ ͏ ͏ ͏&nbs= p;͏ ͏ ͏ ͏ ͏ ͏ &= #847; ͏ ͏ ͏ ͏ ͏ T= 7; ͏ ͏ ͏ ͏ ͏ ͏&= nbsp;͏ ͏ ͏ ͏ ͏ ͏&nbs= p;͏ ͏ ͏ ͏ ͏ ͏ &= #847; ͏ ͏ ͏ ͏ ͏ T= 7; ͏ ͏ ͏ ͏ ͏ ͏&= nbsp;͏ ͏ ͏ ͏ ͏ ͏&nbs= p;͏ ͏ ͏ ͏ ͏ ͏ &= #847; ͏ ͏ ͏ ͏ ͏ T= 7; ͏ ͏ ͏ ͏ ͏ ͏&= nbsp;͏ ͏ ͏ ͏ ͏ ͏&nbs= p;͏ ͏ ͏ ͏ ͏ ͏ &= #847; ͏ ͏ ͏ ͏ ͏ T= 7; ͏ ͏ ͏ ͏ ͏ ͏&= nbsp;͏ ͏ ͏ ͏ ͏ ͏&nbs= p; ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ &sh= y; ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ = ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ &sh= y; ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ = ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ &sh= y; ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ = ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ &sh= y; ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ = ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ &sh= y; ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ = ­ ­ ­ ­ ­

= 3D""
=
3D""

As metabolic research evolves, = two peptides are drawing serious attention for their effects on fat= loss, energy regulation, and insulin sensitivity= =E2=80=94but through entirely different mechanisms.


GLP-3 RETA is = a triple agonist (GLP-1, GIP, and Glucagon) designed to suppress appetite, improve insulin response= , and increase energy expenditure.


MOTS c is a mitochondrial-derived peptide that mimics the effects of exercise and caloric restriction, optimizing fat oxid= ation and cellular energy use without altering fo= od intake.


Both are potent, but they serve= very different research goals. Here=E2=80=99s how they compare.

3D""
GET R= ETA HERE

HOW DOES RETA WORK?

GLP 3 RETA (a GLP 1, GIP, and Glucagon triple agonist)= reduces food intake by suppressing appetite, delaying gastric emptying, an= d improving insulin sensitivity. 


It also promotes energy expenditure through gluca= gon receptor activation. In experimental models, it has shown rapid reducti= ons in body weight, visceral fat, and blood glucose levels (with minimal lo= ss of lean mass).


It may cause nausea, reduced appetite, fatigue, and gast= rointestinal discomfort. These effects are typically transient but dose dep= endent.

HOW DOES MOTS-c WORK?

MOTS= -c is a mitochondrial derived peptide that activates AMPK, a = key energy sensor in cells. It enhances fat oxidation, improves glucose upt= ake, and supports mitochondrial biogenesis, mimicking the cellular effects = of exercise and caloric restriction without altering physical activity.

=


It optimizes= how the body uses stored energy, making it ideal for research focused on e= ndurance, metabolic flexibility, and fat loss.


MOTS-c has s= hown a strong safety profile in animal studies. Reported side effects are m= inimal, with occasional fatigue at higher doses.
3D""
GET M= OTS-C HERE

WHAT KIND OF RESEARCHER = ARE THEY FOR?

If you're studying = obesity, type 2 diabetes, or food-driven metabolic dysfunction, GLP-3 RETA is the go-to compound. Its ability to drastically= reduce food intake while boosting energy expenditure makes it ideal for aggressive weight loss models, particularly in insul= in-resistant or overfed subjects.


On the other hand, MOTS= -c is better suited for researchers focused on mitochondri= al health, athletic performance, or fat loss without appet= ite suppression. It shines in models involving endurance, = aging, or metabolic flexibility, where food intake remains constan= t, but energy output or efficiency needs to be enhanced.


For researchers aiming to reduce fat while maintaining physical output, mitochondrial integrity, or performance, MOTS-c may offer a safer, more sus= tainable model. Research combining both peptides is also very promi= sing.


We are now offering&nbs= p;GLP-3 RETA in 5mg, 10mg, 15mg vials, and MOTS-c= in 10mg vials. They are both sold for research purposes (not for h= uman use).

GET G= LP-3 RETA HERE
GET M= OTS-C HERE

LOOKING FOR OTHER PRODUCTS?

SOMA CHEMS offers well ove= r 100 research compounds, including Selective AR Modulators, Peptides, Amin= os, Research Oils and Nootropics, among many others - <= span style=3D"color:rgb(255,255,255);font-size:16px;">Visit the link below to di= scover our extensive product selection!

SOMAC= HEMS.COM
<= td style=3D"font-size:0;line-height:0;border-top:2px solid #fff;"> 

Edit Preferences or Unsubscribe

=C2=A9 Soma


4703 W 30th Street, Indianapolis, United States, 4= 6222


This email was sent to tjphuhs@gmail.com because y= ou've subscribed on our site or made a purchase.

--2cb382b13505d730ef48f2b7df7c7fe2a45023ff3991e04700510bcddd3d--